急性脑梗死合并高血糖患者胰岛素强化治疗的临床研究

Patients with Acute Cerebral Infarction Merger Hyperglycemia Insulin In-Tensive Therapy Clinical Research

目的分析胰岛素强化治疗急性脑梗死合并高血糖临床疗效。方法选取从2014年9月—2015年9月收治的76例脑梗死合并高血糖患者,按照随机数字法分为对照组(38例)与观察组(38例),对照组采取常规治疗,观察组采取胰岛素强化治疗,对比两组神经功能缺损评分、疗效以及不良反应。结果观察组总有效率为94.74%,对照组为73.68%,观察组高于对照组(P<0.05)。治疗前两组神经功能缺损评分差异无统计学意义(P>0.05);治疗后观察组神经功能缺损评分低于对照组(P<0.05)。观察组不良反应发生率为7.89%,对照组为26.32%,观察组低于对照组(P<0.05)。结论对急性脑梗死合并高血糖患者采取胰岛素强化治疗,可改善患者预后,具有临床应用价值。

Objective To analysis the insulin intensive therapy of acute cerebral infarction combined clinical curative effect of high blood sugar. Selection. Methods From September 2014 to September 2015 were treated 76 cases of patients with cerebral infarction combined high blood sugar, according to the method of random Numbers were divided into control group（38） and observation group（38）, the control group treated with conventional, observation group to take insulin intensive treatment, compared two groups of nerve function defect scale, curative effect and adverse reactions. Results The total effective rate was 94.74%, observing group, control group was 73.68%, the observation group is higher than the control group（P〈0.05）. Two groups before treatment neural function defect scale has no obvious difference（P〈0.05）; Observation group of nerve function defect score lower than the control group after treatment（P〉0.05）. Observation group, the incidence of adverse reactions was 7.89%, control group was 26.32%, the observation group is lower than the control group（P〈0.05）. Conclusion In patients with acute cerebral infarction combined high blood sugar to insulin intensive treatment, can improve the prognosis of patients, the clinical application value.